175 related articles for article (PubMed ID: 20007548)
21. Gene-dosage effects in Down syndrome and trisomic mouse models.
Gardiner K
Genome Biol; 2004; 5(10):244. PubMed ID: 15461808
[TBL] [Abstract][Full Text] [Related]
22. Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.
Hoeller S; Bihl MP; Tzankov A; Chaffard R; Hirschmann P; Miny P; Kühne T; Bruder E
Hum Pathol; 2014 May; 45(5):1003-9. PubMed ID: 24746204
[TBL] [Abstract][Full Text] [Related]
23. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
[TBL] [Abstract][Full Text] [Related]
24. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.
Xu G; Nagano M; Kanezaki R; Toki T; Hayashi Y; Taketani T; Taki T; Mitui T; Koike K; Kato K; Imaizumi M; Sekine I; Ikeda Y; Hanada R; Sako M; Kudo K; Kojima S; Ohneda O; Yamamoto M; Ito E
Blood; 2003 Oct; 102(8):2960-8. PubMed ID: 12816863
[TBL] [Abstract][Full Text] [Related]
25. Congenital GATA1-mutated myeloproliferative disorder in trisomy 21 complicated by placental fetal thrombotic vasculopathy.
Loh TJ; Lian DW; Iyer P; Lam JC; Kuick CH; Aung AC; Chang KT
Hum Pathol; 2014 Nov; 45(11):2364-7. PubMed ID: 25248574
[TBL] [Abstract][Full Text] [Related]
26. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
[TBL] [Abstract][Full Text] [Related]
27. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
Lange AW; Rothermel BA; Yutzey KE
Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
[TBL] [Abstract][Full Text] [Related]
28. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
Dewald GW; Diez-Martin JL; Steffen SL; Jenkins RB; Stupca PJ; Burgert EO
Am J Med Genet Suppl; 1990; 7():247-50. PubMed ID: 2149957
[TBL] [Abstract][Full Text] [Related]
29. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
[TBL] [Abstract][Full Text] [Related]
30. Influence of allelic differences in Down syndrome.
Roper RJ; Hawley L; Goodlett CR
Prog Brain Res; 2020; 251():29-54. PubMed ID: 32057311
[TBL] [Abstract][Full Text] [Related]
31. Trisomy 21 in transient myeloproliferative disorder.
Faed MJ; Robertson J; Todd AS; Sivakumaran M; Tarnow-Mordi WO
Cancer Genet Cytogenet; 1990 Sep; 48(2):259-64. PubMed ID: 2144465
[TBL] [Abstract][Full Text] [Related]
32. Trisomy 21 enhances human fetal erythro-megakaryocytic development.
Chou ST; Opalinska JB; Yao Y; Fernandes MA; Kalota A; Brooks JS; Choi JK; Gewirtz AM; Danet-Desnoyers GA; Nemiroff RL; Weiss MJ
Blood; 2008 Dec; 112(12):4503-6. PubMed ID: 18812473
[TBL] [Abstract][Full Text] [Related]
33. Perinatal loss of Ts65Dn Down syndrome mice.
Roper RJ; St John HK; Philip J; Lawler A; Reeves RH
Genetics; 2006 Jan; 172(1):437-43. PubMed ID: 16172497
[TBL] [Abstract][Full Text] [Related]
34. Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): production of viable trisomy 16 diploid mouse chimeras.
Cox DR; Smith SA; Epstein LB; Epstein CJ
Dev Biol; 1984 Feb; 101(2):416-24. PubMed ID: 6229437
[TBL] [Abstract][Full Text] [Related]
35. Kcnj6(GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of down syndrome.
Joshi K; Shen L; Cao F; Dong S; Jia Z; Cortez MA; Snead OC
Epilepsy Res; 2018 Sep; 145():82-88. PubMed ID: 29929098
[TBL] [Abstract][Full Text] [Related]
36. Promotion and maintenance of leukemia by ERG.
Tsuzuki S; Taguchi O; Seto M
Blood; 2011 Apr; 117(14):3858-68. PubMed ID: 21321361
[TBL] [Abstract][Full Text] [Related]
37. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
38. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
Olson LE; Richtsmeier JT; Leszl J; Reeves RH
Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
[TBL] [Abstract][Full Text] [Related]
39. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
40. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
